European Commission launches major research mission for cancer


  • Mary Corcoran
  • Univadis Medical News
El acceso al contenido completo es sólo para profesionales sanitarios registrados. El acceso al contenido completo es sólo para profesionales sanitarios registrados.

The European Commission has announced the launch of work on a major new research and innovation (R&I) mission for cancer. 

It is establishing a new ‘mission board’ which will look at ways of delivering solutions to some of the challenges in this field. The board will be chaired by Professor Harald zur Hausen, the Nobel Prize Laureate in Physiology or Medicine. Fourteen other experts will be included on the board, with its full composition due to be announced by the end of this month. 

The first role of the mission board will be to identify the first possible specific missions and to propose concrete targets and timelines for each mission by the end of 2019. The boards will enter discussions with citizens, stakeholders and experts from Member States at the first European Research and Innovation Days in Brussels from 24 to 26 September.

Overall, the European Commission is establishing five new European missions, which it says are inspired by the Apollo 11 mission to put a man on the moon. The new missions will be part of Horizon Europe, the next EU research and innovation programme which has a proposed budget of €100 billion.